Compare Magna International Inc. Common Stock (MGA) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Magna International Inc. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Magna International Inc. Common Stock trades at $63.7 (market cap $17.43B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.24 (market cap $2.28B). The key difference: Magna International Inc. Common Stock is far larger — about 7.6× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Magna International Inc. Common Stock pays a 3.04% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| MGA | SLS | |
|---|---|---|
Market Cap | $17.43B | $2.28B |
Volume | 1,096,759 | 3,128,960 |
Sector | Consumer Cyclical | Health |
52-Week High | $73.05 | $15.46 |
52-Week Low | $43.54 | $1.39 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $22.47B | $2.15B |
Dividend Yield | 3.04% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Magna International Inc. Common Stock
Magna International Inc. is a Canada-based automotive supplier that designs, engineers, and manufactures vehicle systems and components, including body and chassis structures, seating, powertrain, and electronics, and provides complete-vehicle engineering and contract assembly, with manufacturing operations in 28 countries.
Read more on MGA →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
